Indeed, a recent study by Li et al. has added more evidence to show the promising role of anti‐CLL1‐based CAR T‐cells (CD28/CD27 co‐stimulatory) in children with R/R‐AML, which is consistence with our previous report.2 This evidence concerns the gene CD28 and acute myeloid leukemia.